Thiago @cyrilpedia latest research update is out: A new class of antibiotics delivers promising trial results against tuberculosis https://www.nature.com/articles/d41591-022-00114-z
@gpollara @mucida Phase II data at the moment, but an interesting approach. The same company (which has since been phagocytosed by Pfizer) already developed an anti fungal based on a difference anti tRNA synthetase. So fingers crossed. The science is pretty cool, a set of boron-based compounds they've been working on for a while.
@cyrilpedia @mucida ah v interesting, didn't know the background to this drug, thank you